WallStSmart

Clene Inc. (CLNN)vsJBS N.V. (JBS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JBS N.V. generates 42074053% more annual revenue ($84.15B vs $200,000). JBS leads profitability with a 2.5% profit margin vs 0.0%. JBS earns a higher WallStSmart Score of 51/100 (C-).

CLNN

Avoid

22

out of 100

Grade: F

Growth: 4.7Profit: 2.5Value: 5.0Quality: 5.0

JBS

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 5.7Quality: 5.5
Piotroski: 4/9Altman Z: 2.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CLNN.

JBSSignificantly Overvalued (-132.0%)

Margin of Safety

-132.0%

Fair Value

$7.00

Current Price

$15.75

$8.75 premium

UndervaluedFair: $7.00Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLNN1 strengths · Avg: 10.0/10
EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

JBS3 strengths · Avg: 8.3/10
Return on EquityProfitability
24.1%9/10

Every $100 of equity generates 24 in profit

P/E RatioValuation
13.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

CLNN4 concerns · Avg: 2.5/10
Market CapQuality
$62.72M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-17.4%2/10

ROE of -17.4% — below average capital efficiency

Revenue GrowthGrowth
-15.4%2/10

Revenue declined 15.4%

JBS3 concerns · Avg: 2.0/10
Profit MarginProfitability
2.5%3/10

2.5% margin — thin

EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

Debt/EquityHealth
2.561/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CLNN

The strongest argument for CLNN centers on EPS Growth.

Bull Case : JBS

The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.4% demonstrates continued momentum.

Bear Case : CLNN

The primary concerns for CLNN are Market Cap, Profit Margin, Return on Equity.

Bear Case : JBS

The primary concerns for JBS are Profit Margin, EPS Growth, Debt/Equity. Debt-to-equity of 2.56 is elevated, increasing financial risk. Thin 2.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

JBS is growing revenue faster at 13.4% — sustainability is the question.

JBS generates stronger free cash flow (543M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

JBS scores higher overall (51/100 vs 22/100) and 13.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Clene Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.

JBS N.V.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.

Want to dig deeper into these stocks?